Open Access 01-12-2021 | Correction
Correction to: Clinical, radiological and functional outcomes in patients with SARS-CoV-2 pneumonia: a prospective observational study
Published in: BMC Pulmonary Medicine | Issue 1/2021
Login to get accessExcerpt
Following publication of the original article, the authors flagged that a calculation error had been made in the calculation of quality of life scores in Table 5 (specifically, of SF-12).
Normal value
|
Overall (39)
|
CT improving at 3 mo (31)
|
CT not improving at 3 mo (8)
|
P value
|
|
---|---|---|---|---|---|
St George symptoms (median and 25th–75th)
|
12 (9–15)
|
16.3 (10.4–29.8)
|
16.3 (10.4–29.8)
|
20.5 (6.5–31.7)
|
0.84
|
St George activity (median and 25th–75th)
|
9 (7–12)
|
19 (12.2–41.4)
|
18.1 (6.3–35.5)
|
40.1 (18.8–69.6)
|
0.08
|
St George impact (median and 25th–75th)
|
2 (1–3)
|
4 (0–11.5)
|
2 (0–8.2)
|
12.2 (0–414)
|
0.13
|
St George total (median and 25th–75th)
|
6 (5–7)
|
9.9 (7.7–21)
|
9.9 (7.2–16.2)
|
20.4 (8.1–50.5)
|
0.16
|
Abnormal St. George total (n and %)
|
–
|
31 (79.5)
|
24 (77.4)
|
7 (87.5)
|
1
|
SF-12 physical (median and 25th–75th)
|
> 50
|
50.5 (36.1–55)
|
53.1 (41.9–56)
|
32.5 (28.9–52.5)
|
0.051
|
SF-12 mental (median and 25th–75th)
|
> 50
|
54.9 (43.5–59.9)
|
57.5 (49–59.9)
|
53.1 (41.4–58.9)
|
0.64
|
Abnormal SF-12 physical (n and %)
|
–
|
19 (48.7)
|
14 (45.2)
|
5 (62.5)
|
0.45
|
Abnormal SF-12 mental (n and %)
|
–
|
12 (30.8)
|
9 (29)
|
3 (37.5)
|
0.68
|